$25.88
0.963.85%
At Close: -
$25.88
00.00%
After Hours: 4:03 PM EDT
15 minutes delayed
Dianthus Therapeutics
DNTHNASDAQ
Dianthus Therapeutics (NASDAQ:DNTH) Stock, Earnings Estimates, EPS, And Revenue
Dianthus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 3
EPS Estimate
$-0.510
Quarterly Revenue Estimate
$310K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$3.2M
Analyze the earnings history of Dianthus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics | — | -$0.51 | — | — | — | $310.00K | — | — | 08/03/2024 | Get Alert |
| DNTH | Dianthus Therapeutics | -$8.10 | -$0.44 | -$0.54 | -22.73% | $476.00K | $460.00K | $874.00K | 90.00% | 05/09/2024 | Get Alert |
| DNTH | Dianthus Therapeutics | — | -$1.01 | -$0.71 | 29.70% | — | $310.00K | $457.00K | 47.42% | 03/21/2024 | Get Alert |
| DNTH | Dianthus Therapeutics | -$8.90 | — | -$3.78 | — | $1.17M | — | $924.00K | — | 11/09/2023 | Get Alert |
Dianthus Therapeutics (DNTH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.54 | $-0.44 | -22.7 % |
| Dec 2023 | 2024-03-21 | $-0.71 | $-1.01 | 29.7 % |
Dianthus Therapeutics (DNTH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $874.00K | $460.00K | 90.0 % |
| Dec 2023 | 2024-03-21 | $457.00K | $310.00K | 47.4 % |
FAQ
When is Dianthus Therapeutics (NASDAQ:DNTH) reporting earnings?
Dianthus Therapeutics (DNTH) is scheduled to report earnings on August 3, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Dianthus Therapeutics (NASDAQ:DNTH)?
The Actual EPS was $-0.54, which missed the estimate of $-0.44.
What were Dianthus Therapeutics’s (NASDAQ:DNTH) revenues?
The Actual Revenue was $874K, which beat the estimate of $460K.
Browse earnings estimates, EPS, and revenue on all stocks.